Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.
‘Avenue5 Residential Signs Multi-Year Contract Extension with Assurant Multifamily Housing’
https://www.assurant.com/newsroom-detail/NewsReleases/2023/January/assurant-avenue5-residential-multi-year-contract-extension